A syncytium-forming (foamy) virus was isolated from a spider monkey brain cell culture. Cytopathic effect was observed both in the brain culture and in human embryonic kidney cells. Neutralizing antibody was present in the sera of the spider monkey from whom the isolation was made. The virus was inhibited by 5-bromo-2-deoxyuridine (20 utg/ml), contained a ribonucleic acid-dependent deoxyribonucleic acid polymerase, and had an infectivity peak at 1.15 g/cm3 in a sucrose density gradient. The virus passed through a 220-nm but not a 100-nm membrane filter, was chloroform sensitive, and was inactivated at 56 C in 30 min. Hemagglutinating and hemadsorption activity was not noted with a variety of erythrocytes. The virion was spherical, formed in the cytoplasm, and was 105 to 115 nm in diameter. Ring-shaped nucleoids, 45 to 50 nm in diameter, were associated with tubular profiles. The virus was not neutralized by sera prepared against known viruses, including simian foamy virus types 1 through 7, Mason-Pfizer monkey virus, and bovine syncytial and measles viruses. Sera from a rabbit hyperimmunized with the isolate and sera from 19 spider monkeys had neutralizing antibody to the isolate; however, these sera did not cross-react with simian foamy virus types 1 through 7. Neutralizing antibody to the isolate was not detected in sera from 16 humans, 9 rhesus monkeys, and 10 chimpanzees.
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Viruses isolated from a number of primate species, which have as one of their characteristics the induction of syncytia formation in cell cultures, have been referred to as the simian foamy viruses. Viruses which induce syncytia and have biological properties similar to the simian viruses have also been isolated from bovine and feline species (10, 11, 14) . The viruses in this group, referred to in the literature as syncytium-forming viruses, contain ribonucleic acid (RNA), are chloroform sensitive, have a buoyant density of approximately 1.16 g/ml, and have an RNA-dependent deoxyribonucleic acid (DNA) polymerase (7, 14, 15) . In their natural host, they persist in a number of tissues in the presence of neutralizing antibody (5) (6) (7) 16 ).
This study describes the isolation, characteristics, and distribution of a new foamy virus isolated from a spider monkey brain culture grown in vitro. The characteristics are described in relation to the properties of the syncytiumforming group of viruses.
MATERIALS AND METHODS
Explant culture preparation. Cerebral cortical tissue of a spider monkey (S-140) brain was obtained at necropsy. The tissue was placed in Eagle minimal essential medium supplemented with penicillin (100 U/ml), streptomycin (100 ug/ml), and 20% fetal bovine serum inactivated at 56 C for 60 min. Explant tissue cultures were prepared according to the technique described by Rogers et al. (16) Physical and chemical characteristics. Viral sensitivity to 5-iodo-2-deoxyuridine (IUdR) and to 5-bromo-2-deoxyuridine (BUdR) was determined by the method described by Parks and Todaro (14) . Viral sensitivity to chloroform treatment, filtration techniques, and hemagglutination and hemadsorption techniques have previously been described (4, 17, 23) .
RNA-dependent DNA polymerase assay. Spider monkey foamy virus was concentrated from culture media by centrifugation at 100,000 x g through 20% glycerol. The high-speed pellet was tested for DNA polymerase activity by using a variety of templates. Assay with activated DNA was carried out as described by Ross et al. (18) . Assays using the templates poly(rA) .oligo(dT) and poly(rC) .oligo(dG) were conducted as described by Ross et In an attempt to evaluate the experimental host range in vivo and in vitro, mice, hamsters, and various cell lines were used. Newborn mice and hamsters, inoculated by the intracerebral and subcutaneous routes, failed to develop clinical signs of disease when observed for 1 year. In contrast, the virus induced characteris-VOL. 8, 1973 tic CPE on first passage in HEK cell cultures and in human skin and muscle (MA-337), human fetal brain (FL-3000), human sarcoma (MA-160), and Vero cells.
Sensitivity to base analogues. The effects of IUdR and of BUdR on the replication of the spider monkey foamy virus are shown in Tables  1 and 2 . At a concentration of 10-4 M, IUdR inhibited spider monkey foamy virus replication by only 0.5 logs, whereas vaccinia virus was inhibited by 2.1 logs. The addition of thymidine reversed the effect of IUdR. Vesicular stomatitis virus, a control RNA-containing virus, was not inhibited by IUdR.
Spider monkey foamy virus replication was inhibited by 0.5, 1.7, and 2.2 logs by the addition of BUdR at a final concentration of 10, 20, and 50 mg/ml, respectively (Table 2) . Vaccinia virus was inhibited 2.3 logs by BUdR at a concentration of 20 ,ug/ml. The inhibitory effect of BUdR was reduced by the addition of thymidine. Vesicular stomatitis virus was not inhibited by BUdR at concentrations of 20 or 50
;Lg/ml. DNA polymerizing activity. The high-speed pellet derived from supernatant culture media of the spider monkey foamy virus-infected HEK cells contained DNA polymerase activity ( Fig.  1) with different templates. The woolly monkey type-C virus was used as a positive control. The foamy virus polymerase activity exhibited a marked preference for the synthetic template poly(rA) -oligo(dT) when compared with activated DNA similar to the woolly type-C virus RNA-dependent DNA polymerase. Both systems utilized poly(rC) oligo(dG), although less well than with either poly(rA) oligo(dT) or activated DNA similar to previous reports (20) . Cellular DNA polymerases, on the other hand, utilized activated DNA preferentially and had almost no activity with poly(rC) .oligo(dG).
Viral characteristics. The concentrations of spider monkey foamy virus in various fractions collected from virus on a sucrose gradient (10 to 50%) are shown in Fig. 2 . A distinct peak of infectivity was noted in fraction 9, which had a density of 1.15 g/cm3.
Chloroform (Fig. 4) , forming their own colonies. They were frequently lined up along the wall of empty cytoplasmic vacuoles. In contrast, the double membrane-enveloped virions appeared to derive from the nucleoids which were enclosed by tubular membrane profiles, measuring 25 to 30 nm apart (Fig. 5) . The tubular membrane profiles engulfing two or three nucleoids are seen to finally enclose an individual particle to form a complete virion, 105 to 115 nm in diameter (Fig. 6) Spider monkey (S-140) virus relationship to the simian foamy viruses is shown in Table 3 . Serum from spider monkey S-140, from whose tissue the isolation was made, completely neutralized spider monkey foamy virus at a dilution of 1: 32. Antisera to spider monkey foamy virus prepared in a rabbit neutralized the S-140 virus at a dilution of 1:20. The S-140 spider monkey sera and the immunized rabbit sera did not neutralize approximately 100 TCD5O units of simian foamy virus types 1 through 7. In addition, S-140 virus was not neutralized by a 1: 10 dilution of antisera prepared against the seven serotypes of simian foamy viruses.
Spider monkey sera, at a 1:10 dilution, were examined for the presence of neutralizing antibody to the spider monkey foamy virus isolate and to the simian foamy virus types 1 through 7 (Table 4) monkey sera, whereas neutralizing antibody to simian foamy virus types 1 through 7 was not detected in the spider monkey sera tested at a 1: 10 dilution. One spider monkey serum, tested at a 1:4 dilution, neutralized simian foamy virus type 7. Antisera prepared against the following prototype viruses failed to neutralize approximately 100 TCD,O units of spider monkey foamy virus: bovine syncytial virus, Mason-Pfizer monkey virus, SV5, measles, parainfluenza types 1, 2, and 3, respiratory syncytial virus, mumps, herpes aotus types 1 and 2, herpes suis, owl monkey kidney isolate, herpes simplex, herpes-B, herpes saimiri, herpes-T, microtus mouse kidney isolate, and sand rat nuclear inclusion virus. In addition, antisera at a 1:4 dilution, prepared against the two spider monkey herpes viruses herpes ateles and spider monkey herpes, were devoid of neutralizing antibody to S-140 virus.
Epidemiological survey for antibody to S-140 isolate. To determine the distribution of the spider monkey foamy virus in spider monkeys, other subhuman primates, and man, appropriate sera were examined for the presence of neutralizing antibody (Table 5) . Neutralizing antibody to the spider monkey foamy virus was detected in the sera from 19 of 31 (61%) of the spider monkey sera tested at a 1:4 dilution. Neutralizing antibody to S-140 virus was not detected in 9 rhesus monkey or in 10 chimpanzee sera tested. Also, sera at a 1: 4 dilution from seven animal caretakers and nine laboratory personnel were devoid of neutralizing antibody to S-140 virus. grivet (Cercopithecus aethiops), squirrel (Saimiri), African bushbaby (Galago), bonnet (Macaca radiata), and the chimpanzee (Pan) (7-9, 16, 19, 20) . This is the first report of an apparently species-specific foamy virus isolated from a spider monkey (Ateles). This virus has not shown an antigenic relationship by neutralization to the seven serotypes of simian foamy viruses. In addition, antisera prepared against the two herpesviruses isolated from spider monkeys, herpes ateles and spider monkey herpesviruses, do not neutralize the spider monkey foamy virus (7, 12, 13) .
The spider monkey foamy virus displays the basic characteristics of syncytium-forming viruses of simian, bovine, and feline origin. This virus is not inhibited by IUdR and is associated with an RNA-dependent DNA polymerase, indicating that it is an RNA virus. In addition, the virus induces syncytia in vitro, replicates in 811 VOL. 8, 1973 on January 20, 2018 by guest http://iai.asm.org/ Spider monkey foamy the cytoplasm, and is chloroform sensitive. The virus persists in the natural host in the presence of circulating antibody. Low concentrations of BUdR markedly reduced the spider monkey foamy virus infectivity. In contrast, IUdR did not significantly reduce the virus infectivity. The fact that IUdR does not significantly inhibit simian foamy virus production has been reported (6, 9, 21) . Inhibition of simian foamy virus by BUdR and the lack of significant inhibition by IUdR was observed by Parks and Todaro (14) . These authors suggested that since the brominated derivative of uridine resembles thymidine more closely than does the iodinated derivative, the foamy virus reverse transcriptase may be able to discriminate between the two halogenated thymidine analogues.
By electron microscopy, the spider monkey isolate was observed only within the cytoplasm of infected cells. The time of collection of 
